Five things for pharma marketers to know: Wednesday, October 25, 2017

FDA develops resources about biosimilars for HCPs; Biogen negotiates royalties for experimental Alzheimer's drug; GSK Q3 sales driven by HIV, respiratory drugs

from Most popular articles from Medical Marketing and Media http://ift.tt/2lfWghQ